US Asset Management LLC’s Bristol-Myers Squibb BMY Stock Holding History

US Asset Management LLC’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,866	Closed	-$129K	–	134
2023 Q1	$129K	Sell	1,866 -11	-0.6%	-$776	0.13%	148
2022 Q4	$135K	Buy	+1,877	New	+$142K	0.15%	148
2022 Q2	$145K	Buy	1,884 +13	+0.7%	+$990	0.16%	141
2022 Q1	$137K	Buy	+1,871	New	+$126K	0.13%	148
2021 Q4	–	Sell	-3,724	Closed	-$220K	–	141
2021 Q3	$220K	Buy	+3,724	New	+$245K	0.21%	118

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

US Asset Management LLC's BMY Position: Q2 2023 in Review

US Asset Management LLC sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 1,866 shares — an estimated $129K sold.

US Asset Management LLC first reported a position in BMY in Q3 2021 and held it in 5 quarters. The position peaked at $220K in Q3 2021. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

US Asset Management LLC reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
US Asset Management LLC sold 1,866 Bristol-Myers Squibb shares in Q2 2023, an estimated $129K.
US Asset Management LLC first reported a position in Bristol-Myers Squibb in Q3 2021 and held it in 5 quarters.
US Asset Management LLC's Bristol-Myers Squibb position peaked at $220K in Q3 2021.
2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on US Asset Management LLC's 13F filing for Q2 2023, filed 22 Aug 2023.